Maurine D Miner

Dr. Maurine D Miner


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2009 in Nature Reviews Microbiology
Verified
Journal Article
Closed access
PDF file
NFNancy Freitag
Nancy Freitag
GPGary C. Port
Gary C. Port
MMMaurine D Miner
Maurine D Miner

15 August 2009 in Journal of Bacteriology
Verified
Journal Article
Closed access
JCJennifer C. Chang
Jennifer C. Chang
MMMaurine D Miner
Maurine D Miner
APAmit K. Pandey
Amit K. Pandey
WGWendy P. Gill
Wendy P. Gill
NHNada S. Harik
Nada S. Harik
DSDavid R. Sherman
David R. Sherman
Recently, cholesterol was identified as a physiologically important nutrient for Mycobacterium tuberculosis survival in chronically infected mice. However, it remained unclear precisely when cholesterol is available to the bacterium and what additional bacterial functions are required for its metabolism. Here, we show that the igr locus, which we previously found to be essential for intracellular growth and virulence of M . tuberculosis , is required for cholesterol metabolism. While igr -deficient strains grow identically to the wild type in the presence of short- and long-chain fatty acids, the growth of these bacteria is completely inhibited in the presence of cholesterol. Interestingly, this mutant is still able to respire under cholesterol-dependent growth inhibition, suggesting that the bacteria can metabolize other carbon sources during cholesterol toxicity. Consistent with this hypothesis, we found that the growth-inhibitory effect of cholesterol in vitro depends on cholesterol import, as mutation of the mce4 sterol uptake system partially suppresses this effect. In addition, the Δ igr mutant growth defect during the early phase of disease is completely suppressed by mutating mce4 , implicating cholesterol intoxication as the primary mechanism of attenuation. We conclude that M . tuberculosis metabolizes cholesterol throughout infection.

30 March 2022 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
NGNigel Garrett
Nigel Garrett
ATAsa Tapley
Asa Tapley
JAJessica Andriesen
Jessica Andriesen
ISIshen Seocharan
Ishen Seocharan
LFLeigh H Fisher
Leigh H Fisher
LCLawrence Corey
Lawrence Corey
We report a 23% asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) Omicron carriage rate in participants being enrolled into a clinical trial in South Africa, 15-fold higher than in trials before Omicron. We also found lower CD4 + T-cell counts in persons with human immunodeficiency virus (HIV) strongly correlated with increased odds of being SARS-CoV-2 polymerase chain reaction (PCR) positive.

1 December 2014 in Infection and Immunity
Verified
Journal Article
Open access
PDF file
TDTracey A. Day
Tracey A. Day
JMJohn E. Mittler
John E. Mittler
MNMolly R. Nixon
Molly R. Nixon
CTCullen Thompson
Cullen Thompson
MMMaurine D Miner
Maurine D Miner
DSDavid R. Sherman
David R. Sherman
The innate immune response plays an important but unknown role in host defense against Mycobacterium tuberculosis . To define the function of innate immunity during tuberculosis, we evaluated M. tuberculosis replication dynamics during murine infection. Our data show that the early pulmonary innate immune response limits M. tuberculosis replication in a MyD88-dependent manner. Strikingly, we found that little M. tuberculosis cell death occurs during the first 2 weeks of infection. In contrast, M. tuberculosis cells deficient in the surface lipid phthiocerol dimycocerosate (PDIM) exhibited significant death rates, and consequently, total bacterial numbers were reduced. Host restriction of PDIM-deficient M. tuberculosis was not alleviated by the absence of interferon gamma (IFN-γ), inducible nitric oxide synthase (iNOS), or the phagocyte oxidase subunit p47. Taken together, these data indicate that PDIM protects M. tuberculosis from an early innate host response that is independent of IFN-γ, reactive nitrogen intermediates, and reactive oxygen species. By employing a pathogen replication tracking tool to evaluate M. tuberculosis replication and death during infection, we identify both host and pathogen factors affecting the outcome of infection.

1 November 2008 in Microbiology
Verified
Journal Article
Open access
MMMaurine D Miner
Maurine D Miner
GPGary C. Port
Gary C. Port
NFNancy Freitag
Nancy Freitag
The transcriptional activator PrfA is required for the expression of virulence factors necessary for Listeria monocytogenes pathogenesis. PrfA is believed to become activated following L. monocytogenes entry into the cytosol of infected host cells, resulting in the induction of target genes whose products are required for bacterial intracellular growth and cell-to-cell spread. Several mutations have been identified that appear to lock PrfA into its highly activated cytosolic form (known as prfA* mutations). In this study PrfA and five PrfA* mutant proteins exhibiting differing degrees of activity were purified and analysed to define the influences of the mutations on distinct aspects of PrfA activity. Based on limited proteolytic digestion, conformational changes were detected for the PrfA* mutant proteins in comparison to wild-type PrfA. For all but one mutant (PrfA Y63C), the DNA binding affinity as measured by electophoretic mobility shift assay appeared to directly correlate with levels of PrfA mutational activation, such that the high-activity mutants exhibited the largest increases in DNA binding affinity and moderately activated mutants exhibited more moderate increases. Surprisingly, the ability of PrfA and PrfA* mutants to form dimers in solution appeared to inversely correlate with levels of PrfA-dependent gene expression. Based on comparisons of protein activity and structural similarities with PrfA family members Crp and CooA, the prfA* mutations modify distinct aspects of PrfA activity that include DNA binding and protein–protein interactions.

1 June 2009
Verified
Journal Article
Closed access
MMMaurine D Miner
Maurine D Miner
JCJennifer C Chang
Jennifer C Chang
APAmit K Pandey
Amit K Pandey
CSChristopher M Sassetti
Christopher M Sassetti
DSDavid R Sherman
David R Sherman